Medicine and Dentistry
Valrubicin
100%
General Medicine
100%
Atrial Fibrillation
100%
Anticoagulant Therapy
100%
Antithrombotic
100%
Cohort Analysis
100%
Casein Kinase
25%
Patient Compliance
13%
Patient Population
6%
Primary Health Care
6%
Linear Regression Analysis
6%
Biochemistry, Genetics and Molecular Biology
Valrubicin
100%
Progression Free Survival
100%
Overall Survival
100%
Atrial Fibrillation
100%
Biomarker Study
50%
Fluorescence Assay
50%
Multivariate Analysis
50%
Epidermal Growth Factor Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Valrubicin
100%
Overall Survival
33%
Progression Free Survival
33%
Diacylglycerol
25%
Squamous Cell Skin Carcinoma
20%
Systemic Treatment
16%
Fluorescence Assay
16%
Biomarker Study
16%
Epidermal Growth Factor Receptor
16%
Disease
16%
Papilloma
10%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
10%
Cell Nucleus Antigen
10%
Skin Necrosis
10%
Actinic Keratosis
10%
